Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574392 · ClinicalTrials.gov registry record

Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
50
Enrollment target

NCT00574392: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00574392 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574392 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The purpose of this study is to image skin and skin lesions with a new imaging technology called "multiwavelength and coherence confocal reflectance microscopy". This technology uses low intensity laser to image below the surface of the skin. This technology may provide a new way of looking at skin and skin lesions. The goal of this study is to evaluate the images of your skin taken by this microscope. The techniques being evaluated in this study use multi wavelength and coherence confocal reflectance microscopy invivo. The term "in vivo" means in/on a living subject. In this study you will be the living subject and the multi wave length and coherence confocal microscope will be placed on your skin to look at your skin lesions and your normal skin. The confocal microscope uses a weak laser light and a sophisticated lens to image the individual cells that make up the skin. Your lesion will be photographed with high resolution photography. An area near your skin lesion that is clinically normal will also be imaged in the same manner.

Interventions

  • DEVICE Multiwavelength and coherence confocal reflectance microscopy (Vivascope 1500m multiwavelength)

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2006-11
Est. Completion 2013-09

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00574392

The ClinicalTrials.gov registry entry for NCT00574392 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Multiwavelength and coherence confocal reflectance microscopy (Vivascope 1500m multiwavelength) is the first listed.

NCT00574392 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00574392 about?

NCT00574392 is a clinical study titled "Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo". The purpose of this study is to image skin and skin lesions with a new imaging technology called "multiwavelength and coherence confocal reflectance microscopy". This technology uses low intensity laser to image below the surface of the skin. This technology may provide a new way of looking at skin ...

What is the current status of trial NCT00574392?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2006-11. Estimated completion is 2013-09.

What interventions are being tested in trial NCT00574392?

The interventions under investigation include: Multiwavelength and coherence confocal reflectance microscopy (Vivascope 1500m multiwavelength) (DEVICE).

Who is sponsoring clinical trial NCT00574392?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.